Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
- PMID: 10548453
- DOI: 10.1080/004982599238173
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
Abstract
1. To aid in the prediction of drug interactions with alprazolam, the human CYP involved in the 1'- and 4-hydroxylation of alprazolam were characterized using human liver microsomes, expressed enzymes and selective chemical inhibitors. 2. The formation of 4-hydroxyalprazolam and 1'-hydroxyalprazolam at an alprazolam concentration of 62.5 microM were reduced by the prototypic CYP3A inhibitor, troleandomycin (50 microM), by 97 and 9900 respectively. Only microsomes from B-lymphoblastoid cells expressing CYP3A4 were capable of catalysing the 1'- and 4-hydroxylation of alprazolam. 3. The formation rates of 1'-hydroxyalprazolam and 4-hydroxyalprazolam at an alprazolam concentration of 1 mM were significantly correlated (n = 19, r = 0.95, p<0.01) indicating that the same enzyme(s) mediated these biotransformations. A significant (p<0.01) correlation was observed between alprazolam 4- and 1'-hydroxylase activity and CYP3A-mediated midazolam 4-hydroxylase, midazolam 1'-hydroxylase, dextromethorphan N-demethylase and erythromycin N-demethylase activities. 4. In conclusion, in adult human liver the CYP3A subfamily members are the principal enzymes involved in the 1'- and 4-hydroxylation of alprazolam. Thus, clinically significant drug drug interactions between alprazolam and other CYP3A substrates are to be expected.
Similar articles
-
Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily.Drug Metab Dispos. 1997 May;25(5):623-30. Drug Metab Dispos. 1997. PMID: 9152603
-
Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.Xenobiotica. 1999 Sep;29(9):899-907. doi: 10.1080/004982599238146. Xenobiotica. 1999. PMID: 10548450
-
Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A.J Pharm Pharmacol. 1998 Sep;50(9):997-1004. doi: 10.1111/j.2042-7158.1998.tb06914.x. J Pharm Pharmacol. 1998. PMID: 9811160
-
Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.J Clin Psychopharmacol. 1999 Aug;19(4):293-6. doi: 10.1097/00004714-199908000-00001. J Clin Psychopharmacol. 1999. PMID: 10440454 Review. No abstract available.
-
Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.J Pharmacokinet Biopharm. 1996 Oct;24(5):475-90. doi: 10.1007/BF02353475. J Pharmacokinet Biopharm. 1996. PMID: 9131486 Review.
Cited by
-
Changes in Alprazolam Metabolism by CYP3A43 Mutants.Biomedicines. 2022 Nov 23;10(12):3022. doi: 10.3390/biomedicines10123022. Biomedicines. 2022. PMID: 36551778 Free PMC article.
-
Irreversible Enzyme Inhibition Kinetics and Drug-Drug Interactions.Methods Mol Biol. 2021;2342:51-88. doi: 10.1007/978-1-0716-1554-6_3. Methods Mol Biol. 2021. PMID: 34272691
-
Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.Eur J Clin Pharmacol. 2012 May;68(5):571-7. doi: 10.1007/s00228-011-1163-8. Epub 2011 Dec 9. Eur J Clin Pharmacol. 2012. PMID: 22159869
-
Complex drug interactions of HIV protease inhibitors 2: in vivo induction and in vitro to in vivo correlation of induction of cytochrome P450 1A2, 2B6, and 2C9 by ritonavir or nelfinavir.Drug Metab Dispos. 2011 Dec;39(12):2329-37. doi: 10.1124/dmd.111.038646. Epub 2011 Sep 19. Drug Metab Dispos. 2011. PMID: 21930825 Free PMC article.
-
Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers.Eur J Clin Pharmacol. 2007 Feb;63(2):173-9. doi: 10.1007/s00228-006-0230-z. Epub 2007 Jan 3. Eur J Clin Pharmacol. 2007. PMID: 17200836
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources